Admin costs - contract orientation & kick off MTG, DTP-17-039, 08/01/17 - 09/30/17, HHSN261201700014I, analysis of anti-cancer chemical & pharmaceutical formulations PRB
Ended Awarded
- Contract number
- HHSN26100001
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $895
Award facts
- Opportunity
-
- N02CM7700416 Solicitation number
- Analysis of Anti-Cancer Chemicals & Pharmaceutical Formulations Award Notice · Posted Feb 22, 2017
- Analysis of Bulk Drugs & Pharmaceutical Formulations Award Notice · Posted Dec 9, 2016
- Contract value 100% obligated
- $895.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Menlo Park, CA 94025, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN26100001?
HHSN26100001 was awarded to Sri International by National Cancer Institute (National Institutes of Health) on August 1, 2017.
How much is contract HHSN26100001 worth?
The government has obligated $895 on HHSN26100001.
Is contract HHSN26100001 an order under another contract?
Yes. HHSN26100001 is a delivery order under HHSN261201700014I, an indefinite delivery contract, on NIH Analysis of Anti-Cancer Chemicals 2017-2022.
Was contract HHSN26100001 competed?
The extent of competition for HHSN26100001 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award